Man Group plc Sells 269,541 Shares of Azenta, Inc. (NASDAQ:AZTA)

Man Group plc lowered its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 97.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 5,944 shares of the company's stock after selling 269,541 shares during the period. Man Group plc's holdings in Azenta were worth $297,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Lord Abbett & CO. LLC bought a new stake in Azenta during the 4th quarter valued at $47,350,000. Conestoga Capital Advisors LLC lifted its holdings in shares of Azenta by 65.0% in the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company's stock worth $78,894,000 after buying an additional 621,830 shares in the last quarter. Norges Bank bought a new position in shares of Azenta in the fourth quarter worth approximately $25,403,000. Schroder Investment Management Group increased its position in shares of Azenta by 46.7% in the fourth quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company's stock worth $70,183,000 after purchasing an additional 447,292 shares during the last quarter. Finally, Marshall Wace LLP purchased a new position in shares of Azenta during the fourth quarter worth approximately $20,469,000. Institutional investors and hedge funds own 99.08% of the company's stock.

Azenta Price Performance

Shares of NASDAQ AZTA traded up $0.23 during midday trading on Thursday, reaching $27.33. 845,028 shares of the stock traded hands, compared to its average volume of 695,056. The stock has a market capitalization of $1.25 billion, a PE ratio of -9.17 and a beta of 1.64. Azenta, Inc. has a one year low of $23.91 and a one year high of $63.58. The company's 50 day moving average is $28.23 and its 200 day moving average is $40.50.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. During the same period in the previous year, the business posted $0.06 EPS. The business's quarterly revenue was up 5.1% on a year-over-year basis. As a group, equities analysts forecast that Azenta, Inc. will post 0.53 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have recently issued reports on AZTA. TD Cowen upgraded shares of Azenta to a "hold" rating in a report on Thursday, February 27th. Needham & Company LLC decreased their target price on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th. Finally, Evercore ISI upped their price target on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research report on Thursday, February 6th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.